PVI
KALA icon

Pura Vida Investments’s KALA BIO KALA Stock Holding History

Pura Vida Investments’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-175
Closed -$3.84M – 132
2020
Q1 		$3.84M Buy
+175
New +$2.8M 0.46% 48
2018
Q2 		– Sell
-6
Closed -$237K – 109
2018
Q1 		$237K Buy
+6
New +$228K 0.14% 64

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pura Vida Investments's KALA Position: Q1 2020 in Review

Pura Vida Investments sold out of KALA BIO (KALA) in Q1 2020, closing a stake of 214 shares — an estimated $3.42M sold.

Pura Vida Investments first reported a position in KALA in Q1 2018 and held it in 6 quarters. The position peaked at $2.47M in Q1 2019. 83 funds tracked by Wall St. Rank hold KALA as of Q1 2020.

  • Pura Vida Investments reported no remaining KALA BIO position as of Q1 2020 after selling out during the quarter.
  • Pura Vida Investments sold 214 KALA BIO shares in Q1 2020, an estimated $3.42M.
  • Pura Vida Investments first reported a position in KALA BIO in Q1 2018 and held it in 6 quarters.
  • Pura Vida Investments's KALA BIO position peaked at $2.47M in Q1 2019.
  • 83 funds tracked by Wall St. Rank held KALA BIO as of Q1 2020.

Based on Pura Vida Investments's 13F filing for Q1 2020, filed 15 May 2020.